ethosuximide has been researched along with Psychotic Disorders in 5 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Following the demonstration of an anti-tremor effect of ethosuximide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) monkey model, we have tested the effect of this drug in 10 patients with typical parkinsonian tremor." | 9.07 | Ethosuximide and tremor in Parkinson's disease: a pilot study. ( Bédard, PJ; Gomez-Mancilla, B; Pourcher, E, 1992) |
| "Following the demonstration of an anti-tremor effect of ethosuximide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) monkey model, we have tested the effect of this drug in 10 patients with typical parkinsonian tremor." | 5.07 | Ethosuximide and tremor in Parkinson's disease: a pilot study. ( Bédard, PJ; Gomez-Mancilla, B; Pourcher, E, 1992) |
| "A 50-year-old man with known multidrug resistant coexistent focal and generalised epilepsy was commenced on ethosuximide, with normalisation of his electroencephalogram and cessation of absence seizures." | 3.85 | Development of forced normalisation psychosis with ethosuximide. ( Apap Mangion, S; Rugg-Gunn, F, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apap Mangion, S | 1 |
| Rugg-Gunn, F | 1 |
| Chakraborty, AT | 1 |
| Youssef, I | 1 |
| Pourcher, E | 1 |
| Gomez-Mancilla, B | 1 |
| Bédard, PJ | 1 |
| Wells, CE | 1 |
| Fischer, M | 1 |
| Korskjaer, G | 1 |
| Pedersen, E | 1 |
1 trial available for ethosuximide and Psychotic Disorders
| Article | Year |
|---|---|
Ethosuximide and tremor in Parkinson's disease: a pilot study.
Topics: Adult; Aged; Antipsychotic Agents; Ethosuximide; Female; Humans; Male; Middle Aged; Neurologic Exami | 1992 |
4 other studies available for ethosuximide and Psychotic Disorders
| Article | Year |
|---|---|
Development of forced normalisation psychosis with ethosuximide.
Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Diagnosis, Differential; Electroencephalogra | 2017 |
Successful treatment of intractable post-ictal psychosis with adjunctive ethosuximide.
Topics: Adult; Anticonvulsants; Ethosuximide; Humans; Male; Psychotic Disorders | 2009 |
Petit mal status presenting as psychasis.
Topics: Anticonvulsants; Depression; Electroencephalography; Epilepsy, Absence; Ethosuximide; Female; Humans | 1973 |
Psychotic episodes in Zarondan treatment. Effects and side-effects in 105 patients.
Topics: Adolescent; Adult; Child; Child, Preschool; Electroencephalography; Epilepsy; Ethosuximide; Female; | 1965 |